Abstract 16535: Angiotensin II Receptor Blocker (ARB) in Combination With Neprilysin Inhibition is Superior to ARB Alone in the Setting of Heart Failure

Introduction: EntrestoTM (LCZ696) combines valsartan, an angiotensin receptor blocker (ARB), and sacubitril, a neprilysin inhibitor (NEPi). LCZ696 was recently approved for use in heart failure (HF...